Norvasc REDUCES the risk of heart attack and stroke

There's new evidence that Norvasc REDUCES the risk of heart attack and patients with coronary artery disease.

This is especially important because of all the news a few years ago about a HIGHER risk of heart attack with some calcium blockers...mostly SHORT-acting nifedipine.

This sparked a lot of research on LONG-acting calcium blockers...Norvasc (amlodipine), Plendil (felodipine), etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote